Hepatocellular carcinoma (HCC) is a neoplasm the incidence of which is increasing worldwide,
but striking geographical differences are observed for both risk factors and occurrence [1]…

Cirrhosis is an increasing cause of morbidity and mortality in more developed countries, being
the 14th most common cause of death worldwide but fourth in central Europe. Increasingly…

Background Patients undergoing liver transplantation for hepatocellular carcinoma within
the Milan criteria (single tumour ≤5 cm in size or ≤3 tumours each ≤3 cm in size, and no …

BACKGROUND & AIMS:: A staged prognostic model of cirrhosis based on varices, ascites,
and bleeding has been proposed. We analyzed data on infections in patients with cirrhosis to …

Background Nonselective beta-adrenergic blockers decrease portal pressure and prevent
variceal hemorrhage. Their effectiveness in preventing varices is unknown. Methods We …

Background & Aims: Our aim was to identify predictors of clinical decompensation (defined
as the development of ascites, variceal hemorrhage [VH], or hepatic encephalopathy [HE]) in …

Background Chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular
carcinoma (HCC). The optimal schedule, or whether embolization (TAE) alone gives …

Bacterial infections are very common and represent one of the most important reasons of
progression of liver failure, development of liver-related complications, and mortality in patients …

Since 1968 the European Liver Transplant Registry (ELTR) collects prospectively the data of
liver transplantation (LT) in 145 centers all over Europe. It represents more than 95% of the …

The intermediate stage of hepatocellular carcinoma (HCC) comprises a highly heterogeneous
patient population and therefore poses unique challenges for therapeutic management, …